SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-001230
Filing Date
2021-01-26
Accepted
2021-01-26 09:16:58
Documents
3
Period of Report
2021-01-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210126_8k.htm 8-K 39217
2 EXHIBIT 4.1 ex_222593.htm EX-4.1 110190
3 EXHIBIT 10.1 ex_222594.htm EX-10.1 56498
  Complete submission text file 0001437749-21-001230.txt   207244
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 21551869
SIC: 2834 Pharmaceutical Preparations